Brain Blood Clot Remover Clears FDA; Comparison Found In Stroke Drug Study
This article was originally published in The Gray Sheet
Executive Summary
Concentric Medical averted a randomized clinical trial requirement for Merci Retriever by convincing FDA that a single-arm study backs 510(k) clearance of the embolic retrieval system
You may also be interested in...
FDA Issues Guidance On Trials For Stroke-Treatment Devices
Neurothrombectomy device trials should be designed to show that stroke patients are more likely to have a good outcome with the device than with an established therapy, FDA advises in a June 18 guidance
FDA Issues Guidance On Trials For Stroke-Treatment Devices
Neurothrombectomy device trials should be designed to show that stroke patients are more likely to have a good outcome with the device than with an established therapy, FDA advises in a June 18 guidance
Cyberonics Banking On Appeals To Avoid VNS Randomized Trial Requirement
Cyberonics will defer a new randomized trial of its VNS Therapy depression indication until it can determine whether an appeal of FDA's recent not-approvable decision may be successful